28
September 2022
Advancing Gene Therapy Research for a Devastating Rare Disease
Neurofibromatosis Type II (NF2) doesn’t debilitate people all at once. Patients may lose part of their hearing or vision or mobility, and there may be quiet stretches in-between. But what […]
Stories